Search

everythinglearnresearchcommunity

for

Search:↓

Men with baldness have higher levels of specific proteins, suggesting local hormone production may play a role in hair loss.

Acne severity in women with PCOS is linked to younger age, lower body weight, and more body hair, but not to hormone levels.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Acne is an important sign of androgen excess disorders in women.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Men with male pattern hair loss have different levels of certain hormones compared to men without hair loss.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Most cases of excessive hair growth in women are caused by polycystic ovarian syndrome and are linked to higher free testosterone levels.

Women with mild acne are more likely to have polycystic ovary syndrome (PCOS) than those without acne.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

High levels of male hormones are very common in women with PCOS and affect their metabolism differently depending on their weight.

The document concludes that careful evaluation is needed to diagnose PCOS correctly due to similar symptoms in other conditions, and accurate testosterone level measurement is crucial.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Adrenal gland disease is common in ferrets and causes hair loss and other symptoms.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

Finasteride works better for hair loss in patients 26 or younger.

Low-dose finasteride effectively reduces hirsutism without serious side-effects.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

Spironolactone can reduce hair growth and testosterone in hirsutism, but is less effective than combined treatments.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

Blood tests are needed to confirm high male hormone levels in women with PCOS, as physical signs alone are not reliable.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.